SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001628280-21-013404
Filing Date
2021-07-02
Accepted
2021-07-02 08:39:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFM14A sema4proxy.htm DEFM14A 7669339
2 a18251_cmlifesciencesproxy.jpg GRAPHIC 14093873
3 proxycard1d.jpg GRAPHIC 4109852
  Complete submission text file 0001628280-21-013404.txt   32148272
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39482 | Film No.: 211068099
SIC: 8000 Services-Health Services